A patient with facial and neck swelling, dyspnea, and dysphagia

Annals of Allergy, Asthma and Immunology

Volumn 95, Issue 6, 2005, Pages 510-517

  Copeland, Billy ^a   Aljitawi, Omar ^a   Fitzgerald, Steven M ^a,b   Chi, David S ^a,b   Krishnaswamy, Guha ^a,b  

^a East Tennessee State University   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; ANTIHISTAMINIC AGENT; CIMETIDINE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; DOXORUBICIN; FLUOROURACIL; HYDROXYZINE; OLANZAPINE; PAROXETINE; ROFECOXIB; SIMVASTATIN; STANOZOLOL; STEROID; THYROXINE; TRANEXAMIC ACID;

ADULT; ALLERGIC REACTION; ANGIONEUROTIC EDEMA; ANTICOAGULANT THERAPY; ASPIRATION BIOPSY; ASTHMA; BREAST CARCINOMA; BRONCHOSCOPY; CASE REPORT; DISEASE ASSOCIATION; DYSLIPIDEMIA; DYSPHAGIA; DYSPNEA; FACE EDEMA; FEMALE; HEARING LOSS; HUMAN; HYPOTHYROIDISM; MASTECTOMY; MEDIASTINOSCOPY; MENTAL DEFICIENCY; PRIORITY JOURNAL; REVIEW; RHINITIS; SUPERIOR CAVA VEIN OBSTRUCTION; THORAX RADIOGRAPHY;

EID: 29444436354     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61011-3     Document Type: Article

References (52)

1. Carreer FM. The C1 inhibitor deficiency: a review. Eur J Clin Chem Clin Biochem. 1992;30:793-807.
2. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161:2417-2429.
3. Christie DR, Kirk JA, Clarke CL, Boyages J. Association of hereditary angioedema and hereditary breast cancer. Cancer Genet Cytogenet. 1997;95:159-162.
4. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet. 2000;356:213-217.
5. Cugno M, Nussberger J, Cicardi M, Agostoni A. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol. 2003;3:311-317.
6. Gadek JE, Hosea SW, Gelfand JA, et al. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N Engl J Med. 1980;302:542-546.
7. Cohen G, Peterson A. Treatment of hereditary angioedema with frozen plasma. Ann Allergy. 1972;30:690-692.
8. Gelfand JA, Sherins RJ, Alling DW, Frank MM. Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities. N Engl J Med. 1976;295:1444-1448.
9. Hosea SW, Frank MM. Danazole in the treatment of hereditary angioedema. Drugs. 1980;19:370-372.
10. Hosea SW, Santaella ML, Brown EJ, Berger M, Katusha K, Frank MM. Long-term therapy of hereditary angioedema with danazol. Ann Intern Med. 1980;93:809-812.
11. Frank M, Gelfand JA, Alling DW, Sherins RJ. Epsilon aminocaproic acid for hereditary angioedema. N Engl J Med. 1977;296:1235-1236.
12. Binkley KE, Davis A III. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol. 2000;106:546-550.
13. Martin L, Degenne D, Toutain A, Ponard D, Watier H. Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission. J Allergy Clin Immunol. 2001;107:747-748.
14. Bork K, Dewald G. Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex. Am J Med. 2004;116:644-645.
15. Agostoni A, Aygoren-Pursun E, Binkley KE, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114:551-8131.
16. Cicardi M, Zingale LC, Pappalardo E, Folcioni A, Agostoni A. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore). 2003;82:274-281.
17. Gelfand JA, Boss GR, Conley CL, Reinhart R, Frank MM. Acquired C1 esterase inhibitor deficiency and angioedema: a review. Medicine (Baltimore). 1979;58:321-328.
18. Cicardi M, Bisiani G, Cugno M, Spath P, Agostoni A. Autoimmune C1 inhibitor deficiency: report of eight patients. Am J Med. 1993;95:169-175.
19. Sheffer AL, Austen KF, Rosen FS, Fearon DT. Acquired deficiency of the inhibitor of the first component of complement: report of five additional cases with commentary on the syndrome. J Allergy Clin Immunol. 1985;75:640-646.
20. Heymann WR. Acquired angioedema. J Am Acad Dermatol. 1997;36:611-615.
21. Farkas H, Csepregi A, Nemesanszky E, et al. Acquired angioedema associated with chronic hepatitis C. J Allergy Clin Immunol. 1999;103:711-712.
22. Farkas H, Gyeney L, Majthenyi P, Fust G, Varga L. Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Z Gastroenterol. 1999;37:513-518.
23. Farkas H, Szongoth M, Bely M, et al. Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis. Acta Derm Venereol. 2001;81:298-300.
24. Markovic SN, Inwards DJ, Frigas EA, Phyliky RP. Acquired C1 esterase inhibitor deficiency. Ann Intern Med. 2000;132:144-150.
25. Jackson J, Sim RB, Whelan A, Feighery C. An IgG autoantibody which inactivates C1-inhibitor. Nature. 1986;323:722-724.
26. Alsenz J, Lambris JD, Bork K, Loos M. Acquired C1 inhibitor (C1-INH) deficiency type II: replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies. J Clin Invest. 1989;83:1794-1799.
27. Pavletic A. Late angioedema caused by ACE inhibitors under-estimated. Am Fam Phys. 2002;66:956-958.
28. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med. 1992;117:234-242.
29. Inman WH, Rawson NS, Wilton LV, Pearce GL, Speirs CJ. Postmarketing surveillance of enalapril, I: results of prescription-event monitoring. BMJ. 1988;297:826-829.
30. Cohen EG, Soliman AM. Changing trends in angioedema. Ann Otol Rhinol Laryngol. 2001;110:701-706.
31. Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor-associated angioedema. JAMA. 1997;278:232-233.
32. Chase MP, Fiarman GS, Scholz FJ, MacDermott RP. Angioedema of the small bowel due to an angiotensin-converting enzyme inhibitor. J Clin Gastroenterol. 2000;31:254-257.
33. Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA. 1988;260:967-970.
34. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf. 2001;24:599-606.
35. van Rijnsoever EW, Kwee-Zuiderwijk WJ, Feenstra J. Angioneurotic edema attributed to the use of losartan. Arch Intern Med. 1998;158:2063-2065.
36. Irons BK, Kumar A. Valsartan-induced angioedema. Ann Pharmacother. 2003;37:1024-1027.
37. Mullins RJ, Shanahan TM, Dobson RT. Visceral angioedema related to treatment with an ACE inhibitor. Med J Aust. 1996;165:319-321.
38. Van Dellen R, Maddox D, Dutta E. Masqueraders of angioedema and urticaria. Ann Allergy Asthma Immunol. 2002;88:10-15.
39. Parish JM, Marschke RF Jr, Dines DE, Lee RE. Etiologic considerations in superior vena cava syndrome. Mayo Clin Proc. 1981;56:407-413.
40. Perez CA, Presant CA, Van AA III. Management of superior vena cava syndrome. Semin Oncol. 1978;5:123-134.
41. Bell DR, Woods RL, Levi JA. Superior vena caval obstruction: a 10-year experience. Med J Aust. 1986;145:566-568.
42. Davenport D, Ferree C, Blake D, Raben M. Response of superior vena cava syndrome to radiation therapy. Cancer. 1976;38:1577-1580.
43. Haapoja IS, Blendowski C. Superior vena cava syndrome. Semin Oncol Nurs. 1999;15:183-189.
44. Escalante CP. Causes and management of superior vena cava syndrome. Oncology (Huntingt). 1993;7:61-68.
45. Markman M. Diagnosis and management of superior vena cava syndrome. Cleve Clin J Med. 1999;66:59-61.
46. Fine DG, Shepherd RF, Welch TJ. Thrombolytic therapy for superior vena cava syndrome. Lancet. 1989;1:1200-1201.
47. Montgomery JH, D'Souza VJ, Dyer RB, Formanek AG, Prabhu SH. Nonsurgical treatment of the superior vena cava syndrome. Am J Cardiol. 1985;56:829-830.
48. Jiamton S, Swad-Ampiraks P, Kulthanan K, Suthipinittharm P. Urticaria and angioedema in Siriraj medical students. J Med Assoc Thai. 2003;86:74-81.
49. Armstrong BA, Perez CA, Simpson JR, Hederman MA. Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phys. 1987;13:531-539.
50. Ostler PJ, Clarke DP, Watkinson AF, Gaze MN. Superior vena cava obstruction: a modern management strategy. Clin Oncol (R Coll Radiol). 1997;9:83-89.
51. Mahajan V, Strimlan V, Ordstrand HS, Loop FD. Benign superior vena cava syndrome. Chest. 1975;68:32-35.
52. Stanford W, Jolles H, Ell S, Chiu LC. Superior vena cava obstruction: a venographic classification. AJR Am J Roentgenol. 1987;148:259-262.